This is a newsroom ThinkIn. In-person and digital-only tickets are available.
The pandemic created sudden and huge demand for all kinds of things that were in short supply, from hand sanitiser to PPE, in turn creating the perfect conditions for unscrupulous businesspeople to drive up prices. Early in the pandemic, media attention in the UK especially focused on cronyism – government officials were accused of leveraging their priviledged access to funding, and to PPE supply chains, to line their own pockets. Now, questions are being asked about the behaviour of some vaccine manufacturers, around unfair pricing, contract fulfilment and communications about the safety and efficacy of ‘competitor’ vaccines. What do we know about the ethics of major pharmaceutical companies before the pandemic, and how might this affect our understanding of what’s happened since?
You can order Billy’s book here.
editor and invited experts
Award-winning reporter for The Times specialising in the pharmaceutical industry. His work has been recognised by the UK Press Awards, the British Journalism Awards and the Medical Journalists’ Association. He is the author of Sick Money: The Truth About The Global Pharmaceutical Industry
Editor and Partner, Tortoise
Dr Raj Thamotheram
Co-Founder of the Pharma Shareowners Group and Pharma Futures
Director/Founder of the Health Justice Initiative (HJI)
Head of Inequality Policy, Oxfam